Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,953 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
关于阳普医疗（郴州）有限公司完成工商注销登记的公告
Regulatory Filings Classification · 96% confidence The document is a regulatory announcement by Yangpu Medical Technology Co., Ltd. regarding the completion of the cancellation (deregistration) of its wholly owned subsidiary. It is not a financial report, earnings release, board change, or other specific category. It falls under miscellaneous regulatory filings.
2026-05-21 Chinese
关于全资子公司取得医疗器械注册证的公告
Regulatory Filings Classification · 87% confidence The document is a brief corporate announcement in Chinese stating that the company’s wholly-owned subsidiary has obtained a medical device registration certificate from the National Medical Products Administration. It contains no financial statements, no executive appointments, no share transactions, no dividends, no AGM materials, and no investor presentation content. It is a routine regulatory disclosure of product approval. Per the classification rules, such miscellaneous regulatory notices that do not fit into more specific categories fall under Regulatory Filings (RNS).
2026-05-14 Chinese
关于全资子公司收到医疗器械变更注册（备案）文件的公告
Regulatory Filings Classification · 90% confidence The document is an official announcement by Yangpu Medical Technology’s board regarding its subsidiary receiving a medical device change registration (filing) document from a regulatory authority. It does not present financial statements, voting results, dividends, or any capital/financing measures, nor is it a proxy, ESG report, or call transcript. It is a general regulatory announcement of an approval/certification by the Guangdong Medical Products Administration. This fits the fallback category for miscellaneous regulatory filings (RNS).
2026-05-14 Chinese
2026年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is a '2026 First Quarter Report' (2026年第一季度报告) for Yangpu Medical Technology Co., Ltd. It contains comprehensive financial statements (Balance Sheet, Income Statement, Cash Flow Statement), management discussion and analysis of financial performance, and shareholder information. It is a full quarterly financial report, not an announcement or a summary, and meets the criteria for an Interim/Quarterly Report (IR). Q1 2026
2026-04-21 Chinese
第六届董事会第十九次会议决议公告
Report Publication Announcement Classification · 85% confidence The document is a board resolution announcement from Yangpu Medical Technology Co., Ltd.’s sixth board of directors approving the 2026 first quarter report, and it directs readers to the full report on the official disclosure website. It does not contain the report itself but announces its board approval and publication. This fits the definition of a Report Publication Announcement (RPA).
2026-04-21 Chinese
关于披露2026年第一季度报告的提示性公告
Report Publication Announcement Classification · 95% confidence The document is a brief notice titled “关于披露2026年第一季度报告的提示性公告” indicating that the company’s 2026 Q1 report has been approved by the board and will be published on April 22 on the designated disclosure website. It does not contain the report itself but announces its upcoming release. This matches the definition for a Report Publication Announcement (RPA).
2026-04-21 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.